The numbers of diagnostic vitamin D and B12 tests ordered in general practice will reduce by a de-implementation strategy, comprising: - education of general practitioners using existing guidelines on vitamin D and B12 tests ordering - techniques…
ID
Bron
Verkorte titel
Aandoening
vitamin D, vitamin B12, diagnostic testing, primary care, education
vitamine D, vitamine B12, diagnostiek, huisarts, scholing
Ondersteuning
Erasmus Medical Center Rotterdam
SALTRO, STAR-MDC
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The reduction in diagnostic vitamin D and B12 tests ordered per 1000 patients in the year after the intervention, as compared to the year prior to the intervention.
Achtergrond van het onderzoek
An every year increasing numbers of vitamin diagnostic tests are being ordered by general practitioners. Often there is no clear clinical reasoning or indication for these tests. Furthermore, this testing has been shown to result in over-diagnosing, over-treatment, medicalization, with very limited health benefits. The REVERT study aims to reduce unnecessary ordering of vitamin D and B12 diagnostic tests in primary care by educating general practitioners about merits and pitfalls of vitamin D and B12 testing and communication about this topic and these tests with their patients. Education will be based on existing, evidence-based current primary care guidelines. The additional value of informing patients will also be investigated.
Doel van het onderzoek
The numbers of diagnostic vitamin D and B12 tests ordered in general practice will reduce by a de-implementation strategy, comprising:
- education of general practitioners using existing guidelines on vitamin D and B12 tests ordering
- techniques for general practitioners to communicate and discuss this topic with their patients
- feedback for practices on numbers of vitamin tests in the previous years
- educational materials for patients
Onderzoeksopzet
Primary and secondary endpoints will be determined by comparing data from a complete year after the intervention to those from a complete year prior to the intervention.
After the intervention, about 10 general practitioners and about 10 patients will be interviewed.
Onderzoeksproduct en/of interventie
The intervention, targeted at general practitioners, will be a meeting (Diagnostisch Toets Overleg) in which education on existing guidelines for vitamin D and B12 and communication with patients about this topic will be offered by an expert. General practitioners will also receive feedback on the history of vitamin D and B12 tests ordering of their practices.
In the other arm, general practitioners have the same educational meeting, and patients in their practices will be informed about this topic using written information material and via screens in the waiting room.
Publiek
University Medical Center Utrecht
A.W. Velden, van der
Utrecht
The Netherlands
088-756 85 11
a.w.vandervelden@umcutrecht.nl
Wetenschappelijk
University Medical Center Utrecht
A.W. Velden, van der
Utrecht
The Netherlands
088-756 85 11
a.w.vandervelden@umcutrecht.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
General practitioners willing to participate in this intervention trial. No individual patients will be included. In total, 30-40 Dutch primary care practices will participate.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Not relevant, as the intervention is targeted at general practitioners, not at patients.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6069 |
NTR-old | NTR6216 |
Ander register | : 839201002_REVERT |